Delta-Radiomics Features Predict Response and Outcome in Head and Neck Cancer Patients Treated with Chemoradiation

被引：0
|
作者：
Florez, E. [1 ]
Thomas, T. [1 ]
Lirette, S. [1 ]
Fatemi, A. [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
来源：
MEDICAL PHYSICS | 2019年 / 46卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
MO-E115-Ge
引用
收藏
页码：E242 / E242
页数：1
相关论文
共 50 条
  • [41] Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation
    Kazmierska, Joanna
    Bajon, Tomasz
    Winiecki, Tomasz
    Borowczak, Dominika
    Bandurska-Luque, Anna
    Jankowska, Malgorzata
    Zmijewska-Tomczak, Malgorzata
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2023, 28 (03) : 389 - 398
  • [42] Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Guo, Liangcun
    Du, Siyao
    Gao, Si
    Zhao, Ruimeng
    Huang, Guoliang
    Jin, Feng
    Teng, Yuee
    Zhang, Lina
    CANCERS, 2022, 14 (14)
  • [43] Delta Radiomics can predict complete pathological response in rectal cancer patients
    Angrisani, A.
    Di Pietro, T.
    D'Ippolito, E.
    Nardone, V.
    Sangiovanni, A.
    Reginelli, A.
    Guida, C.
    Cappabianca, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1563 - S1564
  • [44] Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer
    Fave, Xenia
    Zhang, Lifei
    Yang, Jinzhong
    Mackin, Dennis
    Balter, Peter
    Gomez, Daniel
    Followill, David
    Jones, Aaron Kyle
    Stingo, Francesco
    Liao, Zhongxing
    Mohan, Radhe
    Court, Laurence
    SCIENTIFIC REPORTS, 2017, 7
  • [45] Association of pretreatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    Yu, Brian
    Ma, Sung Jun
    Khan, Michael
    Gill, Jasmin
    Iovoli, Austin
    Farrugia, Mark
    Wooten, Kimberly
    Gupta, Vishal
    McSpadden, Ryan
    Kuriakose, Moni A.
    Markiewicz, Michael R.
    Al-Afif, Ayham
    Hicks, Wesley L.
    Seshadri, Mukund
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9
    Nasief, Haidy
    Hall, William
    Zheng, Cheng
    Tsai, Susan
    Wang, Liang
    Erickson, Beth
    Li, X. Allen
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [47] Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens
    Saijo, Ken
    Imai, Hiroo
    Ouchi, Kota
    Sasaki, Keiju
    Yoshida, Yuya
    Kawamura, Yoshifumi
    Taniguchi, Sakura
    Kasahara, Yuki
    Komine, Keigo
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation
    Ganju, Rohit G.
    Morse, Ryan
    Hoover, Andrew
    TenNapel, Mindi
    Lominska, Christopher E.
    RADIOTHERAPY AND ONCOLOGY, 2019, 137 : 117 - 124
  • [49] Association of absolute neutrophil count with outcomes in patients with head and neck cancer treated with chemoradiation
    Gill, Jasmin
    Virk, Jas
    Fekrmandi, Fatemeh
    Iovoli, Austin
    Farrugia, Mark
    Ma, Sung Jun
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Acute toxicity in head and neck cancer patients treated with chemoradiation/cetuximab ± consolidation cetuximab
    Riesterer, O.
    Bertogg, K.
    Shrestha, B.
    Weber, S.
    Bianchi, J.
    Glanzmann, C.
    Studer, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (12) : 1071 - 1071
12345